COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 591: Articles 5901-5910  | Next

Particulate matter air pollution and COVID-19 infection, severity, and mortality: A systematic review
Sheppard, N., Carroll, M., Gao, C. X., Lane, T. J.
10.1101/2022.11.16.22282100 — Posted: 2022-11-17
A single-centre, observational study to evaluate immune response to Covid-19 vaccines in immunocompromised patients with haematological disorders (COVAC-IC)
CHANDRA, D., COAVC-IC INVESTIGATORS, , O'Mara, L., Bailey, L., Aspey, M., Asaduzzaman, M., Banavathi, K., Lea, S., Bowler, R., Prasangika, J., Phillips, N., Wasim, F., Badugama, B., Kamran, N., Perera, K., Bano, F., Pillai, S., Dyer, P., Aquil, M., Goddard, S., Ogbolosingha, A., Remegoso, A., Lee, J., Watts, K., Karunanithi, K.
10.1101/2022.11.16.22282121 — Posted: 2022-11-17
Observational methods for COVID-19 vaccine effectiveness research: a trial emulation and empirical evaluation
Catala, M., Burn, E., Rathod-Mistry, T., Xie, J., Delmestri, A., Prieto-Alhambra, D., Jodicke, A. M.
10.1101/2022.11.09.22282065 — Posted: 2022-11-17
SpikeScape: A Tool for Analyzing Structural Diversity in Experimental Structures of the SARS-CoV-2 Spike Glycoprotein
Stepanenko, D., Simmerling, C.
10.1101/2022.11.15.516662 — Posted: 2022-11-16
Deep-learning based bioactive therapeutic peptides generation and screening
Zhang, H., Saravanan, K. M., Wei, Y., Jiao, Y., Yang, Y., Pan, Y., Wu, X., Zhang, J. Z. H.
10.1101/2022.11.14.516530 — Posted: 2022-11-16
Beta-Cyclodextrins as affordable antivirals to treat coronavirus infection
Raich-Regue, D., Tenorio, R., Fernandez-de-Castro, I., Perez-Zsolt, D., Munoz-Basagoiti, J., Sachse, M., Fernandez-Sanchez, S., Gallemi, M., Ortega-Gonzalez, P., Fernandez-Oliva, A., Gabaldon, J., Nunez-Delicado, E., Casas, J., Tarres, F., Vergara-Alert, J., Segales, J., Carrillo, J., Blanco, J., Clotet, B., Ceron-Carrasco, J., Izquierdo-Useros, N., Risco, C.
10.1101/2022.11.16.516726 — Posted: 2022-11-16
Molecularly distinct memory CD4+ T cells are induced by SARS-CoV-2 infection and mRNA vaccination
Gray-Gaillard, S. L., Solis, S., Monteiro, C., Chen, H., Ciabattoni, G., Samanovic, M. I., Cornelius, A. R., Williams, T., Geesey, E., Rodriguez, M., Ortigoza, M. B., Ivanova, E. N., Koralov, S. B., Mulligan, M. J., Herati, R. S.
10.1101/2022.11.15.516351 — Posted: 2022-11-16
Ethical reporting of research on violence against women and children during COVID-19: Analysis of 75 studies and recommendations for future guidelines
Peterman, A., Devries, K., Guedes, A., Chandan, J. S., Minhas, S., Lim, R. Q. H., Gennari, F., Bhatia, A.
10.1101/2022.11.15.22282363 — Posted: 2022-11-16
Efficient SARS-CoV-2 detection utilizing chitin-immobilized nanobodies synthesized in Ustilago maydis
Philipp, M., Müller, L., Andree, M., Hussnaetter, K. P., Schaal, H., Feldbrügge, M., Schipper, K.
10.1101/2022.11.11.516239 — Posted: 2022-11-16
Assessment of level of depression and associated factors among COVID-19 recovered patients: a cross sectional study
Khatun, M. K., Farhana, N.
10.1101/2022.11.14.22282128 — Posted: 2022-11-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).